<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03550638</url>
  </required_header>
  <id_info>
    <org_study_id>ZHTQ2017001</org_study_id>
    <nct_id>NCT03550638</nct_id>
  </id_info>
  <brief_title>Coil System(Ton-bridgeMT) for Endovascular Embolization of Cranial Aneurysms</brief_title>
  <official_title>The Efficacy and Safety Study on Endovascular Embolization of Intracranial Aneurysms With Coil System(Ton-bridgeMT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhuhai Tonbridge Medical Tech. Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhuhai Tonbridge Medical Tech. Co., Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a prospective, multi-center, randomized, open, parallel positive control,
      non-inferiority trial. Patients are randomized 1:1 to either Coil System(Ton-bridgeMT) or
      Axium Detachable Coil(Medtronic).

      The purpose of this study is to assess the safety and effectiveness of the Coil
      System(Ton-bridgeMT) in the treatment of intracranial aneurysms.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 28, 2018</start_date>
  <completion_date type="Anticipated">May 31, 2020</completion_date>
  <primary_completion_date type="Actual">January 3, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>success rate of occlusion</measure>
    <time_frame>180 day</time_frame>
    <description>Number of aneurysms(Raymond Ⅰ and Ⅱ)/number of overall aneurysms*100%</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>success rate of occlusion</measure>
    <time_frame>intraoperation</time_frame>
    <description>Number of aneurysms(Raymond Ⅰ and Ⅱ)/number of overall aneurysms*100%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence rate</measure>
    <time_frame>180 day</time_frame>
    <description>2. Number of patients with recurrent aneurysms/ number of overall patients*100%</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">256</enrollment>
  <condition>Intracranial Aneurysms</condition>
  <arm_group>
    <arm_group_label>group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Coil system(Ton-bridgeMT)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Axium Detachable Coil(Medtronic)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coil system(Ton-bridgeMT)</intervention_name>
    <description>1. It consists of a push system with a development mark, and a Detachable platinum-tungsten alloy coil which is connected to the push system. It can be used for embolization of intracranial aneurysms, and other neurovascular abnormalities, such as arteriovenous malformation and arteriovenous fistula.</description>
    <arm_group_label>group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Axium Detachable Coil(Medtronic)</intervention_name>
    <description>2. It is made up of a push system with a development mark, a platinum-tungsten alloy embolized coil connected to the push system and a manual release device for releasing the coil from the distal end of the push system. It is mainly used for embolization of intracranial aneurysms, and other neurovascular abnormalities, such as arteriovenous malformation and arteriovenous fistula.</description>
    <arm_group_label>group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-80 years.

          -  Subject has a target intracranial aneurysm (IA) diagnosed by DSA, and intended to be
             embolised with coil system.

          -  Subject or guardian is able to understand the purpose of study, agrees to comply with
             protocol requirements and has provided written informed consent.

        Exclusion Criteria:

          -  Subject is diagnosed as multiple aneurysms.

          -  Subject is diagnosed as intracranial bulloid, fusiform, false, dissectimng, infective
             aneurysm or with arteriovenous malformation.

          -  mRS score≥3.

          -  Hunt and Hess classification≥4.

          -  Subject has emergency ruptured aneurysms and needs assisting stent.

          -  The target aneurysm has received endovascular embolization or surgical treatment.

          -  The aneurysm carrier artery has severe stenosis.

          -  PLT＜60×109/L or INR＞1.5.

          -  Subject has nonfunction of important organs or other severe diseases.

          -  Major surgery in the last 30 days, or intending to receive surgical treatment in 90
             days after enrollment.

          -  Subject is allergic to antiplatelet drugs, anticoagulants, anesthetics, contrast
             agents or any related contraindication.

          -  History of allergies to platinum and tungsten.

          -  Expected life ＜12 months.

          -  Pregnant or lactating women.

          -  Subject has participated in any other drug or medical device clinical trials in 1
             month before writting informed consent .

          -  Other circumstances judged by researchers are not suitable for enrollment .
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jianmin Liu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Changhai Hospital of Shangha</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Danqing Shen</last_name>
    <phone>15858207851</phone>
    <email>dq.shen@ton-bridge.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhongshan People's Hospital</name>
      <address>
        <city>Zhongshan</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhi'an Han</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Guizhou Medical University</name>
      <address>
        <city>Guiyang</city>
        <state>Guizhou</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hua Yang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nanjing Brain Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jun Ma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jiangsu Province Hospital</name>
      <address>
        <city>Nanjin</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haibin Shi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The first hospital of Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Honglei Wang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>First Affiliated Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chuansheng Liang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shengjing Hospital affiliated to China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yunhui Liu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yantai Yuhuangding Hospital</name>
      <address>
        <city>Yantai</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xin Wu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Changhai Hospital of Shanghai</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianmin Liu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tangdu Hospital of The Fourth Military Medical University</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhenwei Zhao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated hospital of Zhejiang University School of Medicine</name>
      <address>
        <city>Hanzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianmin Zhang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guan Sheng</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>May 28, 2018</study_first_submitted>
  <study_first_submitted_qc>May 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2018</study_first_posted>
  <last_update_submitted>March 10, 2020</last_update_submitted>
  <last_update_submitted_qc>March 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

